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Poster Symposia / 54 (2014) S17eS33S32suggests that adolescents and their families can, when given the
option, make informed and reasoned choices about the ﬂow of
information about appointments. Health care providers should
make every effort to provide a range of communication options to
adolescents and not make assumptions about their preferences for
sharing information with parents or guardians.
Sources of Support: SAHM Improving Understanding of Adoles-
cent Vaccination through Innovative Local Public Health Demon-
stration Grant.
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Purpose: Adolescent immunization rates for all vaccines are low
when compared to the high rates of childhood immunization in
the US. This is especially true with multi-dose vaccines, such as
the Human Papilloma Virus (HPV) vaccine. The American Acad-
emy of Pediatrics recommends HPV vaccination for females and
males from 11 to 26 years of age. Missed opportunities for the
HPV vaccine are common. The CDC reports that in 2012, if all
missed opportunities for initiation of HPV vaccination had been
eliminated, coverage with ¼ 1 dose of HPV vaccine could have
reached 92.6%. Even after the vaccine has been initiated, there
are still many occasions for missed opportunities. Adolescents
who are 18-25 years old have particularly low rates of starting
and completing the HPV vaccine. Delayed or non-completion of
HPV series may decrease protection against HPV infection
especially if exposure to HPV occurs prior to completion. Our
objective was to examine HPV series completion in adolescent-
speciﬁc, medicine and family planning clinics and to assess the
frequency of missed opportunities when adolescents come in for
any type of care.
Methods: Electronic medical records were queried for young
women 18-25 years old who initiated the HPV vaccine series in the
Adolescent Medicine, Young Mother’s or Family Planning clinics at
Children’s Hospital Colorado from 1/1/2010 to 12/31/2011. Visits
for preventive or non-preventive care during appropriate dosing
intervals of HPV vaccine where the 2nd (4-14 weeks after 1st dose)
or 3rd (21-40 weeks after 1st dose and >12 weeks after 2nd dose)
doses were not administered were counted as “missed
opportunities.”
Results: 567 females initiated the HPV series during the study
period and 22.2% of these patients completed the full series
within one year of initiation. 33.5% of patients who did not receive
their 2nd dose had at least one missed opportunity visit and 23.8%
of patients who received the 2nd but not 3rd dose had a missed
opportunity for completion. Women who initiated the vaccine in
the Family Planning clinic were less likely to have missed op-
portunities than those who initiated in other adolescent clinics
(29.8% vs. 42.2%; p<0.005). There were no racial or ethnic dif-
ferences between those who completed the series and those who
did not.
Conclusions: A signiﬁcant number of adolescent females who
initiated the HPV vaccine had missed opportunities for continu-
ation and completion. This emphasizes the importance of pro-
vider-awareness of vaccine updates at every adolescent visit. Thelower missed opportunity rate in Family Planning may reﬂect
increased provider knowledge and counseling focused on the
importance of HPV vaccination. Our overall completion rate is
signiﬁcantly lower than previously published rates and may
reﬂect older adolescents’ inexperience in managing their own
preventive health care. Our results clearly identify the need for
provider and patient interventions to improve vaccine series
completion.
Sources of Support: No sources of ﬁnancial support.
60.
VACCINATING SONS AGAINST HPV: RESULTS FROM A U.S.
NATIONAL STUDY OF PARENTS
Jaime Taylor, DO, Gregory Zimet, PhD, FSAHM,
Andreia Alexander, MD, MPH, PhD, Marcia Shew, MD, MPH,
Nathan Stupiansky, PhD.
Indiana University School of Medicine.
Purpose: HPV is the most common sexually transmitted infection.
The quadrivalent HPV vaccination was approved for use in males
ages 9 to 26 in 2009 and recommended for routine administration
in 2011. The purpose of this study was to uncover predictable
commonalities amongst parents who chose to vaccinate their 11-
17 year old sons against HPV.
Methods:We complied data from a U.S. national sample of parents
with sons 11-17 years old using aweb-based survey. Using a survey
research company (SSI), we collected data from a national sample
of U.S. adults in July and August of 2012. This survey covered
parental demographics, political afﬁliation, and religious service
attendance, parental discussion of sexual health topics with their
sons, son’s health care utilization and recent inﬂuenza vaccination
history.We used binary logistic regression tomodel sons’ receipt of
1 or more doses of HPV vaccine. Behavioral and sociodemographic
predictors were ﬁrst modeled individually for univariate associa-
tions and then signiﬁcant predictors (p<.05) were combined in a
multivariable model. All analyses were performed using SPSS 21.
Results: A total of 779 parents (52% female) with a mean age of 42
years (SD 11.54) completed the survey. Overall, 21.7% of parents
reported that their son had received one or more doses of HPV
vaccine. Increasing parental age was associated with decreased
odds of HPV vaccination (OR 0.98; 95% CI 0.96-0.99). Parents who
had discussed sexual health topics with their sonsweremore likely
to vaccinate (OR 1.61; 95% CI 1.37-1.89). Sons who were evaluated
by healthcare providers sometime in the last year more frequently
received at least one dose of the vaccine (OR 2.22; 95% CI 1.12-4.40)
as did those who had received a ﬂu shot in the last two years (OR
1.82; 95% CI 1.45-2.26). Parent gender, religiosity, political afﬁlia-
tion, parental education, and sons’ age were not signiﬁcant pre-
dictors of HPV vaccination.
Adjusted odds ratios, controlled for ethnicity, conﬁrmed that
parental age (AOR 0.98; 95% CI 0.97-0.99), openness to discuss
sexual health with sons (AOR 1.58; 95% CI 1.33-1.88), and receiving
a ﬂu shot in the last two years (AOR 1.71; 95% CI 1.36-2.15)
remained independent predictors of HPV vaccination in a multi-
variate model.
Conclusions: The rate of male vaccination in this study, although
low, is higher than 2011 national CDC data. There is a signiﬁcant
increase in rate of vaccination in those who have had exposure to
health care providers. Both SAHM, and Bright Futures, recommend
routine care for adolescents. This study suggests that vaccination
rates would increase by following this practice. Additionally, the
